drugset
drugset / Trial / NCT05741606

Safety and Efficacy of Sodium Pentaborate Pentahydrate in People With Overweight and Obesity

NCT05741606 ↗

Phase 1/2 Unknown 120 enrolled Tabriz University of Medical Sciences
RandomizedParallel-groupTriple-blindTreatment

Summary

This study investigates the safety and efficacy of sodium pentaborate pentahydrate in improving the body weight and glycemic profile of patients with overweight or obesity compared to the placebo group.

Timeline

Start
2023-07-21
Primary completion
2024-03-20
Completion
2025-03-21

Drugs

EvaluationDrugModalityDoseRoute
Comparator PENTABORATE Small molecule 200 mg Oral
Comparator PENTABORATE Small molecule 400 mg Oral
Comparator PENTABORATE Small molecule 600 mg Oral
Comparator PENTABORATE Small molecule 800 mg Oral
Comparator PENTABORATE Small molecule 1000 mg Oral

Indications

morbid obesity